Axitinib bulk supplier for pharma manufacturers

Axitinib 1 mg, 5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1 mg, 5 mg

Reference Brands: Inlyta®(EU & US)

Axitinib 1 mg and 5 mg Tablets are used in oncology for the treatment of metastatic renal cell carcinoma (RCC). Available under the brand name Inlyta®, Axitinib is a tyrosine kinase inhibitor that targets VEGF receptors to inhibit tumor growth. It is used as a second-line therapy after the failure of prior treatments like sunitinib or pazopanib. Available in oral tablet form, it is typically taken twice daily.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Axitinib 1 mg and 5 mg Tablets are a key treatment for metastatic renal cell carcinoma (RCC), primarily used as a second-line therapy for patients who have failed prior treatments like sunitinib or pazopanib. As a tyrosine kinase inhibitor, Axitinib targets the VEGF receptors involved in tumor angiogenesis, thus slowing the growth of cancer cells. Approved under the brand name Inlyta® in both the U.S. and EU, Axitinib is essential in oncology B2B portfolios for advanced RCC treatment. It is typically administered twice daily in oral tablet form at doses of 1 mg or 5 mg.

Axitinib — third party manufacturing & bulk supply

Axitinib 1 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Axitinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Axitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Axitinib →

Back to Listing

Frequently Asked Questions

Axitinib is listed as Tablets in 1 mg, 5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Axitinib is referenced against Inlyta®(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.